Abstract
Aim of this study was to investigate whether osteoclast activity changes as a consequence of even mild physiological perturbation of plasma calcium as such induced by an oral calcium load. Osteoclast activity was determined indirectly by measuring, in spot urines at two and four hours after oral calcium load, the urinary excretion of hydroxylysylpyridinoline (Pyr), deoxylysylpyridinoline (D-Pyr), hydroxyproline (Hyp) and galactosyl-hydroxylysine (GHyl). The occurrence of the metabolic perturbation of plasma calcium homeostasis was assessed by measuring three indexes: i.e. calcemie response, PTH reduction and calciuric response at times following oral calcium loading. A significant fall of urinary D-Pyr and Pyr followed the perturbation of calcium homeostasis induced by the oral calcium load in two groups of healthy young adult and postmenopausal women. The highest mean percent reduction was observed for D-Pyr and was quantitatively similar in the two groups. Since urinary D-Pyr is the most specific bone resorption marker, it may be inferred that the perturbation of plasma calcium homeostasis induced by an oral calcium load is able to acutely inhibit osteoclast activity. This supports the view that osteoclasts are involved in the short-term error correction of plasma calcium.
Similar content being viewed by others
References
Parfitt A.M. Plasma calcium homeostasis. Bone 8: S1, 1987.
Parfitt A.M. Calcium homeostasis. In: Mundy G.R., Martin T.J., (Eds.), Physiology and Pharmacology of Bone. Springer-Verlag, Berlin Heidelberg, 1993, p. 1.
Goddard M., Young G., Marcus R.. Short-term effects of calcium carbonate, lactate, and gluconate on the calcium-parathyroid axis in normal elderly men and women. Am. J. Clin. Nutr. 44: 653, 1986
Horowitz M., Morris H.A., Hartley T.F., Need A.G., Wishart J., Ryan P., Nordin B.E.C. The effect of an oral calcium load on plasma ionized calcium and parathyroid hormone concentrations in osteoporotic postmenopausal women. Calcif. Tissue Int. 40: 133, 1987.
Lips P., Notelembos C.J., van Doom L, Hackeng W.H.L., Lips C.J.M. Stimulation and suppression of intact parathyroid hormone (PTH 1–84) in normal subjects and hyperparathyroid patients. Clin. Endocrinol. (Oxf.) 35: 35, 1991.
Need A.G., Horowitz M., Philcox J.C., Nordin B.E.C. Biochemical effects of a calcium supplement in osteoporotic postmenopausal women with normal absorption and malabsorption of calcium. Mineral Electrolyte Metab. 13: 112, 1987.
Reginster J.Y., Denis D., Bartsch V., Deroisy R., Zegels B., Franchimont P. Acute biochemical variations induced by four different calcium salts in healthy male volunteers. Osteoporosis Int. 3: 271, 1993.
Thome J.F., Bilezikian J.P., Clemens T.L., Silverberg S.J., Shane E., Lindsay R. Suppression of parathyroid hormone secretion with oral calcium in normal subjects and patients with primary Hyperparathyroidism. J. Clin. Endocrinol Metab. 70: 951, 1990.
Reid I.R., Schooler B.A., Hannan S.F., Ibertson H.K. The acute biochemical effects of four proprietary calcium preparations. Aust. N.Z. J. Med. 16: 193, 1986.
Woo J., Swaminathan R., Lau E., MacDonald D., Pang CP., Nordin B.E.C. Biochemical effects of a single oral dose of calcium on bone metabolism in elderly Chinese women. Calcif. Tissue Int. 48: 157, 1991.
Guillemant S., Guillemant J., Duntze P. Comparison of the biochemical and hormonal acute effects of calcium salts. Osteoporosis Int. 4: 66, 1995.
Horowitz M., Need A.G., Philcox J.C, Nordin B.E.C. Effect of calcium supplementation on urinary hydroxyproline in osteoporotic postmenopausal women. Am. J. Clin. Nutr. 39: 857, 1984.
Horowitz M., Need A.G., Philcox J.C., Nordin B.E.C. The effect of calcium supplements on plasma alkaline phosphatase and urinary hydroxyproline in postmenopausal women. Horm. Metab. Res. 17: 311, 1985.
Horowitz M., Need A.G., Morris H.A., Wishart J., Nordin B.E.C. Biochemical effects of calcium supplementation in postmenopausal osteoporosis. Eur. J. Clin. Nutr. 42: 775, 1988.
Beardsworth L.J., Eyre D.R., Dickson I.R. Changes with age in the urinary excretion of lysylhydroxylysylpyridinoline, the two new markers of bone collagen turnover. J. Bone Min. Res. 5: 671, 1990.
Ohishi T., Kushida K., Takahashi M., Kawana K., Yagi K., Kawakami K., Horiuchi K., Inoue T. Urinary bone resorption markers in patients with metabolic bone disorders. Bone 15: 15, 1994.
Seibel M.J., Robins S.P., Bilezikian J.P. Urinary pyridium crosslinks of collagen: specific markers of bone resorption in metabolic bone disease. Trends Endocrinol. Metab. 3: 263, 1992.
Krane S.M., Kantrowitz F.G., Byre M., Rinnel S.R., Singer F.R. Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation. J. Clin. Invest. 59: 819, 1977.
Askenasi R. Urinary hydroxylysine and hydroxylysyl glycoside excretions in normal and pathological states. J. Lab. Clin. Med. 83: 673, 1974.
Moro L., Pozzi Mucelli R.S., Gazzarrini C, Modricky C, Marotti F., De Bernard B. Urinary galactosyl-O-hydroxylysine as a marker of collagen turnover of bone. Calcif. Tissue Int. 42: 87, 1988.
Gagel R.F. Dynamic tests. In: Favus M.J. (Ed.), Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Raven Press, New York, 1993, p. 418.
Yang R.S., Liu T.K., Tsai K.S. The acute metabolic effects of oral tricalcium phosphate and calcium carbonate. Calcif. Tissue Int. 55: 335, 1994.
Casari E., Ferrero CA., Grazioli V., Murone M. Performance of a modified HPLC method to determine hydroxyprolinuria. Clin. Chem. 38: 2337, 1992.
Grazioli V., Casari E., Murone M., Bonini P.A. High-performance liquid chromatographic method for measuring hydroxylysine glycosides and their ratio in urine as a possible marker of human bone collagen breakdown. J. Chromatogr. 615: 59, 1993.
Eyre D.R., Koob T.T., Van Ness K. Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal. Biochem. 137: 380, 1984.
Silverberg S.J., Bilezikian J.P. Parathyroid function and responsiveness in osteoporosis. In: Bilezikian J.P., Marcus R., Levine M.A. (Eds.), The Parathyroids: Basic and Clinical Concepts. Raven Press, New York, 1994, p. 805.
Rubinacci A., Divieti P., Capponi A., Resmini G., Daverio R., Veglia F., Tessari L. La riduzione delia secrezione di paratormone dopo carico orale di calcio negli adulti osteoporotici. Minerva Endocrinol. 17: 55, 1992.
Cosman F., Shen V., Herrington B., Lindsey R. Response of the parathyroid gland to infusion of human parathyroid hormone (1–34). J. Clin. Endocrinol. Metab. 73: 1345, 1991.
Silverberg S.J., Shane E., Cruz L, Segre R.N., Clemens T.L., Bilezikian J.P. Abnormalities in parathyroid hormone secretion and 1,25-diydroxyvitamin D3 formation in women with osteoporosis. N. Engl. J. Med. 320: 277, 1989.
Wong M.M., Rao LG., Ly K, Hamilton L, Ish-Shalom S., Sturtridge W., Tong J., McBroom R., Josse R.G., Murray T.M. In vitro study of osteoblastic cells from patients with idiopathic osteoporosis and comparison with cells from non-osteoporotic controls. Osteoporosis Int. 4: 21, 1994.
Fox S.J. Regulation of parathyroid hormone secretion by plasma calcium in aging rats. Am. J. Physiol. 260: E220, 1991.
Hassager C, Ristelli L, Jensen S.B., Christiansen C. Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal women. J. Bone Miner. Res. 7: 1307, 1992.
Blumsohn A., Herrington K., Hannon R.A., Shao P., Eyre D.R., Eastell R. The effect of calcium supplementation on the circadian rhythm of bone resorption. J. Clin. Endocrinol. Metab. 79: 730, 1994.
Schlemmer A., Hassanger C, Jensen S.B., Christiansen C. Marked diurnal variation in urinary excretion of pyridinium crosslinks in premenopausal women. J. Clin. Endocrinol. Metab. 7: 476, 1992.
Schlemmer A., Hassager C, Pedersen B.J., Christiansen C. Posture, age, menopause, and osteopenia do not influence the circadian variation in the urinary excretion of pyridinium crosslinks. J. Bone Miner. Res. 9: 1883, 1994.
Jubiz W., Canterbury J.M., Reiss E., Tyler F.H. Circadian rhythm in serum parathyroid hormone concentration in human subjects: correlation with serum calcium, phosphate, albumin, and growth hormone levels. J. Clin. Invest. 51: 2040, 1972.
Buzio C, Arisi L, Capani F., Barani R., Quaretti P. Circadian rhythm of proteinuria in normal subjects but not in patients with glomerulonephritis. Ann. Clin. Res. 19: 30, 1987.
Bollen A.M., Martin M.D., Leroux B.G., Eyre D.R. Circadian variation in urinary excretion of bone collagen. J. Bone Miner. Res. 10: 1885, 1995.
Horowitz M., Wishart J.M., Goh D., Morris H., Need A.G., Nordin B.E.C. Oral calcium suppresses biochemical markers of bone resorption in normal men. Am. J. Clin. Nutr. 60: 965, 1994.
Calvo M.N., Eyre D.R., Gundberg CM. Molecular basis and clinical application of biological markers of bone turnover. Am. J. Clin. Nutr. 60: 965, 1994.
Marabini R., Sirtori P., Chionna R., Barzizza L., Rubinacci A. Galactosylhydroxylysine and pyridinium crosslinks in monitoring the bone response to hormone replacement therapy. J; Endocrinol. Invest. 19: 154, 1996.
Pecile A., Sibilia V., Netti C.. Villa I., Moro G.L., Rubinacci A. Comparison between urinary pyridium crosslinks and hydroxyzine glycosides in monitoring the bone response to ovariectomy and 17β-estradiol replacement in aged rats. J. Endocrinol. 150: 000, 1996.
Rubinacci A., De Ponti A., Shipley A., Samaja M., Karplus E., Jaffe L. Bicarbonate dependence of ionic current in damaged bone. Calcif. Tissue Int. 58: 423, 1996.
Austin L.A., Heath III H., Go V.L.W. Regulation of calcitonin secretion in normal man by changes of serum calcium within the physiological range. J. Clin. Invest. 4: 1721, 1979.
Fuss M., Pepersack T., Corvilain J., Bergmann P., Willems D., Simon J., Body J.J. Stimulation of calcitonin secretion by an oral calcium load test in normal subjects and in idiopathic renal stone formers. Bone Miner. 13: 131, 1991.
Malgaroli A., Meldolesi J., Zambonin Zallone A., Teti A. Control of cytosolic free calcium in rat and chicken osteoclasts. The role of extracellular calcium and calcitonin. J. Biol. Chem. 264: 14342, 1989.
Zaidi M., Datta H.K., Patchell A., Moomga B.S., Maclntyre I. “Calcium-activated” intracellular calcium elevation: a novel mechanism of osteoclast regulation. Biochem. Biophys. Res. Commun. 163: 1461, 1989.
Kanis J., Passmore R. Calcium supplementation of the diet: not justified by the present evidence. BMJ 298: 137, 1989.
Nordin B.E.C, Heaney R.P. Calcium supplementation of the diet: justified by the present evidence. BMJ 300: 1056, 1990.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rubinacci, A., Divieti, P., Polo, R.M. et al. Effect of an oral calcium load on urinary markers of collagen breakdown. J Endocrinol Invest 19, 719–726 (1996). https://doi.org/10.1007/BF03347874
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347874